Firefly Neuroscience is trading 5.17% down now at $1.10, based on the provided live price context; the specific catalyst remains unclear.
- No company-specific announcement dated August 14, 2026, was identified.
- The latest located company update was an August 5 report about a 291% increase in TMS-center brain-scan volumes.
- Broader markets are modestly lower after weaker July retail sales and consumer sentiment, but declines remain below the threshold for a strong market-wide explanation.